Study at Cambridge
About the University
Research at Cambridge
Mobile menu
Mobile menu
Privacy
Cookies
Accessibility
Search
About
About
Our team
Our performance
Careers
The Cambridge ecosystem
Partnerships and collaboration
back
For the University
For the University
Tell us your idea
Be a consultant
Develop a commercial opportunity
Start a company or social venture
Develop your skills & network
Cambridge Enterprise Academic Portal
back
For external organisations
For external organisations
Find a consultant
Opportunities to invest
International outreach
Available technologies
Available research tools
Experts & Mentors Programme
back
Latest
Latest
News
Insights
Case studies
Videos
back
What’s on
Contact us
Posts Tagged ‘drugs’
drugs
Share:
Spin-outs
27 February 2020
PolyProx Therapeutics: a new class of drugs to halt difficult-to-drug cancers
Find out more
Life Sciences
1 November 2018
Seed Fund Investment Manager on BioBeat’s 2018 list of 50 Female Movers and Shakers
Find out more
Spin-outs
4 October 2016
Making medicine simple
Find out more
Technology Transfer
18 May 2016
Cambridge University allies with TeraView to boost drug formulation
Find out more
Life Sciences
8 April 2015
PhoreMost raises £2.5m to identify new targets for therapeutics
Find out more
Life Sciences
7 April 2015
Spin-out X01 acquired by Janssen
Find out more
Life Sciences
16 February 2015
DefiniGEN stem cell research plays vital role in developing new drugs
Find out more
Life Sciences
19 December 2014
First of new generation of cancer drugs granted European approval
Find out more
Life Sciences
1 December 2014
Cambridge academics are winners in GSK’s Discovery Fast Track Challenge
Find out more
Life Sciences
24 October 2014
Lynparza recommended for approval in ovarian cancer
Find out more
Life Sciences
20 March 2014
Official opening of Cambridge labs at Stevenage Bioscience Catalyst
Find out more
Life Sciences
17 September 2013
Cambridge drug approved for treatment of multiple sclerosis
Find out more
1
2
3
Sign up to our newsletter
Stay in touch with the latest updates from Cambridge Enterprise
Sign up now